Canada markets close in 1 hour 56 minutes

Lucid Diagnostics Inc. (LUCD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.4150+0.0150 (+1.07%)
As of 02:03PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close1.4000
Open1.3552
Bid1.4000 x 3200
Ask1.4300 x 1000
Day's Range1.3800 - 1.4500
52 Week Range1.1050 - 3.6400
Volume14,634
Avg. Volume103,416
Market Cap61.402M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    PAVmed and Lucid Diagnostics Provide Strategic Business Update

    NEW YORK, January 17, 2023--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or "Lucid Diagnostics"), a commercial-stage cancer prevention diagnostics company, and Veris Health Inc. ("Veris"), a private digital health company focused on enhanced personalized cancer care, today provided a

  • Business Wire

    PAVmed and Lucid Diagnostics to Provide Strategic Business Update

    NEW YORK, January 11, 2023--Companies will present refinements to their business strategy as each continue to the benefit patients in need and create value for shareholders.

  • Business Wire

    PAVmed Partners with Novosound on Ultrasound Imaging Technology

    NEW YORK, December 22, 2022--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has entered into a license option and joint research and development agreement with Novosound Ltd. ("Novosound"), a venture-backed technology company based in Glasgow, Scotland, to explore applying Novosound’s proprietary flexible thin-film ultrasound technology in me